Antiviral cell therapy: is this the future?

Other literature type English OPEN
Gea-Banacloche, Juan C.;

In this issue of Blood, Leen and colleagues report the first multicenter trial of third-party viral-specific T cells (VSTs) for the treatment of 50 patients with refractory viral infections (cytomegalovirus, adenovirus, and Epstein-Barr virus) after stem cell transplant... View more
Share - Bookmark